| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00228-008-0531-5 |
| P698 | PubMed publication ID | 18654767 |
| P2093 | author name string | G Haase | |
| W Schareck | |||
| B Drewelow | |||
| A Pietsch | |||
| M Sass | |||
| R Mundkowski | |||
| J Majcher-Peszynska | |||
| S Klammt | |||
| P2860 | cites work | Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections | Q80730925 |
| Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy | Q24519008 | ||
| Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections | Q33347869 | ||
| Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections | Q33836490 | ||
| Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses. | Q33836578 | ||
| Clinical efficacy and antimicrobial pharmacodynamics. | Q33873989 | ||
| Intrapulmonary pharmacokinetics of linezolid | Q34106719 | ||
| In vivo pharmacodynamics of a new oxazolidinone (linezolid) | Q34142754 | ||
| Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate | Q34284305 | ||
| Diagnosis and treatment of diabetic foot infections | Q34357233 | ||
| Pharmacokinetics of linezolid in subjects with renal dysfunction | Q35685516 | ||
| Tissue pharmacokinetics of levofloxacin in human soft tissue infections | Q35826148 | ||
| Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents | Q36098587 | ||
| Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs | Q36220885 | ||
| Pharmacokinetics and tissue penetration of linezolid following multiple oral doses | Q39477515 | ||
| Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells. | Q39671242 | ||
| Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis | Q41473712 | ||
| Pharmacokinetic/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model | Q42846091 | ||
| Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock | Q43541038 | ||
| Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid | Q43689994 | ||
| Linezolid levels in pancreatic secretions | Q43815773 | ||
| Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement | Q44049240 | ||
| Linezolid penetration into osteo-articular tissues | Q44198710 | ||
| Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog. | Q44206806 | ||
| Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem | Q44311731 | ||
| Target site penetration of fosfomycin in critically ill patients | Q44385715 | ||
| Intrapulmonary penetration of linezolid | Q44440587 | ||
| Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration | Q44921565 | ||
| Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. | Q45981790 | ||
| Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia | Q46589068 | ||
| Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers | Q46915090 | ||
| Determination of antibiotic drug concentrations in circulating human blood by means of solid phase micro-extraction | Q48568291 | ||
| Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. | Q51592642 | ||
| Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection? | Q57543717 | ||
| Hyperglycaemia and absorption of sulphonylurea drugs | Q69371278 | ||
| Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography | Q73513895 | ||
| Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis | Q74492356 | ||
| P433 | issue | 11 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| linezolid | Q411377 | ||
| P304 | page(s) | 1093-1100 | |
| P577 | publication date | 2008-07-25 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections | |
| P478 | volume | 64 |
| Q38070154 | An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy |
| Q36620071 | Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models |
| Q39278957 | Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients. |
| Q47611899 | Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones |
| Q33397069 | Correlation between serum linezolid concentration and the development of thrombocytopenia |
| Q38283321 | Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis |
| Q37869258 | Linezolid pharmacokinetics and pharmacodynamics in clinical treatment |
| Q37788206 | Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections |
| Q53853180 | Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort |
| Q35838594 | Pharmacokinetics of antiretrovirals in mucosal tissue |
| Q47218572 | Population pharmacokinetic analysis of linezolid in low body weight patients with renal dysfunction. |
| Q36894442 | Unwanted baggage |
Search more.